trending Market Intelligence /marketintelligence/en/news-insights/trending/RD9zY_ngbBSrnJbS9F4USw2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

CannTrust to explore sale, other options under strategic review

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform


CannTrust to explore sale, other options under strategic review

CannTrust Holdings Inc. is undertaking a strategic review that could potentially result in full or partial sale of the company.

A special committee of CannTrust's board hired Greenhill & Co. Canada Ltd. as financial adviser to assist in the review of strategic alternatives, including sale, business combination, strategic investment as well as changes to the company's operations and current business plan.

The committee was formed to investigate Health Canada's compliance report, which said the company was involved in growing cannabis in five unlicensed rooms in its Pelham, Ontario-based greenhouse facility.

The board terminated CEO Peter Aceto as a result of a probe into the illegal cultivation of cannabis that flouted Health Canada regulations, while Eric Paul stepped down as chairman at the board's request.

The company said there is no set timetable for the conclusion of the review and that the exercise may not result in any transaction.

The strategic review process will be influenced by the resolution of the company's regulatory compliance issues with Heath Canada, among others, CannTrust said in a news release.